Oxford Immunotec
Manufacturing · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
143 Park Drive, Abingdon, Oxfordshire, O...Phone Number
+44 1235442780Website
www.oxfordimmunotec.comRevenue
$73.7 MillionIndustry
About Oxford Immunotec
Revvity specializes in T-SPOT Technology, which utilizes the ELISPOT method to measure T cell responses for clinical applications, particularly in infectious disease detection and immune response monitoring. Their product portfolio includes solutions for tuberculosis management, cytomegalovirus testing, and other immune-related diagnostics. Targeting healthcare providers and laboratories, Revvity aims to enhance clinical testing capabilities and improve patient care through innovative technology. With over 20 years of experience in T cell immunology, they are committed to advancing healthcare diagnostics.Explore more
Oxford Immunotec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Oxford Immunotec
Compare insights from companies similar to Oxford Immunotec, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Oxford Immunotec Tech Stack
A closer look at the technologies used by Oxford Immunotec
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oxford Immunotec
Sign Up For FreeTo access detailed company insights
Revvity specializes in T-SPOT Technology, which utilizes the ELISPOT method to measure T cell responses for clinical applications, particularly in infectious disease detection and immune response monitoring. Their product portfolio includes solutions for tuberculosis management, cytomegalovirus testing, and other immune-related diagnostics. Targeti... Read More
